Case Reports
31 March 2025

Peritoneal involvement in acute pericarditis with polyserositis may mimic acute cholecystitis: a case report

Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
235
Views
99
Downloads

Authors

Acute pericarditis is an inflammatory disease of the pericardium that can exclusively affect the pericardium or extend and affect other serosae, including pleura and peritoneum. The involvement and dysregulation of the inflammasome, a protein complex responsible for the innate immune response, appear to be central in these forms of idiopathic pericarditis. This multi-district interest leads to considering recurrent pericarditis also as a possible systemic disease. Here, we report the case of a 56-year-old male with a negative past medical history who presented with dyspnea, chest and abdominal pain, and low-grade fever. Routine investigations and echocardiography were consistent with acute pericarditis; a chest X-ray revealed pleural effusion and an abdominal ultrasound detected modest peritoneal effusion and cholecystitis. The symptoms completely regressed within 24 hours of initiating therapy with non-steroidal anti-inflammatory drugs and colchicine. The pericardial, pleural, and peritoneal effusions, along with cholecystitis, regressed in the next 4 weeks. This is the first reported case in which pericarditis with polyserositis also involved the gallbladder in the inflammatory process. It appears that standard therapy for pericarditis was effective in inducing remission of the extracardiac inflammatory processes, further supporting the hypothesis of an autoinflammatory etiology for the cholecystic inflammatory process as well. Early identification of pericarditis with systemic involvement implies shorter hospitalization times and improved therapeutic classification of the patient, thereby reducing the likelihood of corticosteroid-dependent pericarditis and significantly lowering the risk of relapse.

Altmetrics

Downloads

Download data is not yet available.

Citations

Adler Y, Charron P, Imazio M, et al. 2015 ESC guidelines for the diagnosis and management of pericardial diseases. Rev Esp Cardiol 2015;68:1126. DOI: https://doi.org/10.1016/j.rec.2015.10.008
Imazio M, Gaita F, LeWinter M. Evaluation and treatment of pericarditis: a systematic review. JAMA. 2015;314:1498-506. DOI: https://doi.org/10.1001/jama.2015.12763
Reddy P, Kane GC, Oh JK, Luis SA. The evolving etiologic and epidemiologic portrait of pericardial disease. Can J Cardiol 2023;39:1047-58. DOI: https://doi.org/10.1016/j.cjca.2023.05.011
Del Buono MG, Bonaventura A, Vecchié A, et al. Pathogenic pathways and therapeutic targets of inflammation in heart diseases: a focus on interleukin-1. Eur J Clin Invest 2024;54:e14110. DOI: https://doi.org/10.1111/eci.14110
Bizzi E, Trotta L, Pancrazi M, et al. Autoimmune and autoinflammatory pericarditis: definitions and new treatments. Curr Cardiol Rep 2021;23:128. DOI: https://doi.org/10.1007/s11886-021-01549-5
Tombetti E, Casarin F, Bizzi E, et al. Relapsing pericarditis: peripheral blood neutrophilia, lymphopenia and high neutrophil-to-lymphocyte ratio herald acute attacks, high-grade inflammation, multiserosal involvement, and predict multiple recurrences. Int J Rheum Dis 2023;26:337-43. DOI: https://doi.org/10.1111/1756-185X.14523
Pisacreta AM, Mascolo R, Nivuori M, et al. Acute pericarditis with pleuropulmonary involvement, fever and elevated C-reactive protein: a systemic autoinflammatory disease? A cohort study. Eur J Intern Med 2023;113:45-8. DOI: https://doi.org/10.1016/j.ejim.2023.03.034
Wei Q, Sun L. Monogenic autoinflammatory disease-associated cardiac damage. Inflamm Res 2023;72:1689-93 DOI: https://doi.org/10.1007/s00011-023-01771-7
Sönmez HE, Bayındır Y, Batu ED. Cardiovascular manifestations of monogenic periodic fever syndromes. Clin Rheumatol 2023;42:2717-32. DOI: https://doi.org/10.1007/s10067-023-06504-z
Wu MA, Costedoat-Chalumeau N, Maestroni S, Brucato A. Acute pericarditis or a systemic disease with pleuropulmonary involvement? Intern Emerg Med 2019;14:731-3. DOI: https://doi.org/10.1007/s11739-019-02057-9
Brucato A, Brambilla G, Moreo A, et al. Long-term outcomes in difficult-to-treat patients with recurrent pericarditis. Am J Cardiol 2006;98:267-71. DOI: https://doi.org/10.1016/j.amjcard.2006.01.086
Lazaros G, Antonopoulos AS, Imazio M, et al. Clinical significance of pleural effusions and association with outcome in patients hospitalized with a first episode of acute pericarditis. Intern Emerg Med 2019;14:745-51. DOI: https://doi.org/10.1007/s11739-019-02041-3
Stoichitoiu LE, Ionescu GD, Neatu I, Baicus C. Causes of polyserositis: a systematic review. J Pers Med 2023;13:834. DOI: https://doi.org/10.3390/jpm13050834
Cavalli G, Colafrancesco S, Emmi G, et al. Interleukin 1α: a comprehensive review on the role of IL-1α in the pathogenesis and treatment of autoimmune and inflammatory diseases. Autoimmun Rev 2021;20:102763. DOI: https://doi.org/10.1016/j.autrev.2021.102763
Lazaros G, Vlachakis PK, Theofilis P, et al. D-dimer as a diagnostic and prognostic plasma biomarker in patients with a first episode of acute pericarditis. Eur J Intern Med 2023;116:58-64. DOI: https://doi.org/10.1016/j.ejim.2023.06.017

How to Cite



Peritoneal involvement in acute pericarditis with polyserositis may mimic acute cholecystitis: a case report. (2025). Italian Journal of Medicine. https://doi.org/10.4081/itjm.2025.1931